                         SEQUENCE LISTING

<110>  Susavion Biosciences, Inc.
 
<120>  Compositions and Methods for Treating Cancer and Persistent Viral Infections

<130>  24667.030

<150>  US 14/697,240
<151>  2015-04-27

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  1

Val Gly Gly Gly Ser 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  2

His Pro Ser Leu Lys 
1               5 

<210>  3
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  3

Asn Pro Ser His Pro Leu Ser Gly 
1               5   


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  4

Asn Pro Ser His Pro Ser Leu Gly 
1               5     


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  5

Asn Gln His Thr Pro Arg 
1               5      


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  6

Gly Gly Gly Ser 
1               


<210>  7
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  7

Gly Gly Gly Ser Gly Gly Gly Ser 
1               5               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  8

Ser Ser Ser Ser 
1               


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  9

Ser Ser Ser Ser Ser Ser Ser Ser 
1               5                 

<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  10

His Pro Ser Leu Gly 
1               5   


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  11

His Pro Ser Leu Leu 
1               5               


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Sequence

<400>  12

His Pro Ser Leu Ala 
1               5             